BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 38490767)

  • 21. Applications of next-generation sequencing in hematologic malignancies.
    Ramkissoon LA; Montgomery ND
    Hum Immunol; 2021 Nov; 82(11):859-870. PubMed ID: 33648805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview. Cytogenetic analysis in haematology.
    Bain BJ
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):463-77. PubMed ID: 11640865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Gachard N; Lafage-Pochitaloff M; Quessada J; Auger N; Collonge-Rame MA
    Curr Res Transl Med; 2023; 71(4):103416. PubMed ID: 37865978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetics in the management of hematologic malignancies: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
    Nguyen-Khac F; Daudignon A; Eclache V; Lafage-Pochitaloff M; Lefebvre C; Luquet I; Penther D
    Ann Biol Clin (Paris); 2016 Oct; 74(5):509-510. PubMed ID: 27465598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From genomics to targeted treatment in haematological malignancies: a focus on acute myeloid leukaemia.
    Jakobsen NA; Vyas P
    Clin Med (Lond); 2018 Apr; 18(Suppl 2):s47-s53. PubMed ID: 29700093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
    Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
    Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular pathology: intersection of morphology, biochemistry and genetics].
    Bosman FT
    Ned Tijdschr Geneeskd; 1999 Nov; 143(45):2269-75. PubMed ID: 10578428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
    Atluri H; Gerstein YS; DiNardo CD
    Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in next-generation sequencing and emerging technologies for hematologic malignancies.
    Kwon R; Yeung CCS
    Haematologica; 2024 Feb; 109(2):379-387. PubMed ID: 37584286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular diagnostics.
    Braziel RM; Shipp MA; Feldman AL; Espina V; Winters M; Jaffe ES; Petricoin EF; Liotta LA
    Hematology Am Soc Hematol Educ Program; 2003; ():279-93. PubMed ID: 14633786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole genome scanning as a cytogenetic tool in hematologic malignancies.
    Maciejewski JP; Mufti GJ
    Blood; 2008 Aug; 112(4):965-74. PubMed ID: 18505780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.
    Kanagal-Shamanna R; Singh RR; Routbort MJ; Patel KP; Medeiros LJ; Luthra R
    Expert Rev Mol Diagn; 2016; 16(4):461-72. PubMed ID: 26765348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Diagnostic Testing for Hematopoietic Neoplasms: Linking Pathogenic Drivers to Personalized Diagnosis.
    Hergott CB; Kim AS
    Clin Lab Med; 2022 Sep; 42(3):325-347. PubMed ID: 36150815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular findings in myeloid neoplasms.
    Tran TB; Siddon AJ
    Int J Lab Hematol; 2023 Aug; 45(4):442-448. PubMed ID: 37345257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Necessity of Genetic Examination in Treatment for Hematological Malignancies].
    Kiyoi H
    Rinsho Byori; 2015 Mar; 63(3):369-76. PubMed ID: 26524860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia.
    Antić Ž; Lentes J; Bergmann AK
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101511. PubMed ID: 38092485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytogenetic biomarkers for human cancer.
    Keen-Kim D; Nooraie F; Rao PN
    Front Biosci; 2008 May; 13():5928-49. PubMed ID: 18508633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FISH panels for hematologic malignancies.
    Sreekantaiah C
    Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Introduction to the molecular diagnostic methods of oncohematology].
    Király AP; Alpár D; Fésüs V; Marosvári D; Matolcsy A; Bödör C
    Magy Onkol; 2016 Jun; 60(2):88-98. PubMed ID: 27275635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
    DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
    Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.